Arisa Kobayashi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Arisa Kobayashi has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Akio Nakashima
Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine , Tokyo 105-8461
1 shared publication - Chiharu Aizawa
Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine , Tokyo 105-8461
1 shared publication - Ichiro Ohkido
Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine , Tokyo 105-8461
1 shared publication - Kazuhiko Kato
Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine , Tokyo 105-8461
1 shared publication - Mitsuyoshi Urashima
Division of Molecular Epidemiology, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-Ku, Tokyo 105-8461, Japan
1 shared publication - Shunichiro Shinagawa
Department of Psychiatry The Jikei University School of Medicine Tokyo Japan
1 shared publication
Latest Publications
- Open Access
- 5 August 2026
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 10 (10)
Bone turnover markers associated with cognitive dysfunction in patients undergoing hemodialysis: a cross-sectional study
Cognitive impairment is common in patients undergoing hemodialysis; however, evidence linking routinely measured bone turnover markers to cognition remains limited. In this exploratory cross-sectional study, we aimed to evaluate whether bone-specific alkaline phosphatase (BAP), total alkaline phosphatase (ALP), and tartrate-resistant acid phosphatase 5b (TRACP-5b) are related to global cognitive function in older patients undergoing hemodialysis. Adults aged ≥65 yr receiving maintenance hemodialysis were enrolled at seven centers in Tokyo and Chiba, Japan (November 2021-November 2022). Global cognition was assessed using the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE). Multivariable linear regression with robust SEs and facility fixed effects was used to examine associations with MoCA scores across sequentially adjusted models. Because of a ceiling effect, MMSE was analyzed using logistic regression with MMSE ≤23 as the outcome (unadjusted and age-/sex-adjusted). For statistical analyses, bone turnover markers were natural log-transformed. Among 380 participants (median age 74 yr; 67.6% male), higher BAP was consistently associated with lower MoCA scores (fully adjusted β −1.03; 95% CI, −1.90 to −0.16). Total ALP showed inverse associations in less-adjusted models; however, these associations attenuated after full adjustment (β −.88; 95% CI, −1.89 to 0.14). TRACP-5b was not clearly associated with MoCA scores. Higher BAP and total ALP were associated with higher odds of MMSE-defined cognitive dysfunction, whereas TRACP-5b was not. These findings suggest a potential association between bone formation-related markers and cognitive performance in older patients undergoing hemodialysis. Prospective and mechanistic studies are warranted to clarify causality and clinical utility.
- 5 August 2026
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 10 (10)
Open AccessBone turnover markers associated with cognitive dysfunction in patients undergoing hemodialysis: a cross-sectional study
Cognitive impairment is common in patients undergoing hemodialysis; however, evidence linking routinely measured bone turnover markers to cognition remains limited. In this exploratory cross-sectional study, we aimed to evaluate whether bone-specific alkaline phosphatase (BAP), total alkaline phosphatase (ALP), and tartrate-resistant acid phosphatase 5b (TRACP-5b) are related to global cognitive function in older patients undergoing hemodialysis. Adults aged ≥65 yr receiving maintenance hemodialysis were enrolled at seven centers in Tokyo and Chiba, Japan (November 2021-November 2022). Global cognition was assessed using the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE). Multivariable linear regression with robust SEs and facility fixed effects was used to examine associations with MoCA scores across sequentially adjusted models. Because of a ceiling effect, MMSE was analyzed using logistic regression with MMSE ≤23 as the outcome (unadjusted and age-/sex-adjusted). For statistical analyses, bone turnover markers were natural log-transformed. Among 380 participants (median age 74 yr; 67.6% male), higher BAP was consistently associated with lower MoCA scores (fully adjusted β −1.03; 95% CI, −1.90 to −0.16). Total ALP showed inverse associations in less-adjusted models; however, these associations attenuated after full adjustment (β −.88; 95% CI, −1.89 to 0.14). TRACP-5b was not clearly associated with MoCA scores. Higher BAP and total ALP were associated with higher odds of MMSE-defined cognitive dysfunction, whereas TRACP-5b was not. These findings suggest a potential association between bone formation-related markers and cognitive performance in older patients undergoing hemodialysis. Prospective and mechanistic studies are warranted to clarify causality and clinical utility.